These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12569963)

  • 21. Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.
    Figgitt DP; Noble S
    Drugs; 2002; 62(4):705-22. PubMed ID: 11893235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment.
    Camargo CH; Cattai L; Teive HA
    Toxins (Basel); 2015 Jun; 7(6):2321-35. PubMed ID: 26110508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Botulinum toxin for the treatment of pain syndromes].
    Ferreira JJ; Couto M; Costa J; Coelho M; Rosa MM; Sampaio C
    Acta Reumatol Port; 2006; 31(1):49-62. PubMed ID: 17058384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature.
    Sycha T; Kranz G; Auff E; Schnider P
    J Neurol; 2004 Feb; 251 Suppl 1():I19-30. PubMed ID: 14991339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug therapy for the treatment of chronic nonspecific low back pain: systematic review and meta-analysis.
    Chung JW; Zeng Y; Wong TK
    Pain Physician; 2013; 16(6):E685-704. PubMed ID: 24284847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of botulinum toxin type-B in the treatment of patients who have become unresponsive to botulinum toxin type-A -- initial experiences.
    Barnes MP; Best D; Kidd L; Roberts B; Stark S; Weeks P; Whitaker J
    Eur J Neurol; 2005 Dec; 12(12):947-55. PubMed ID: 16324088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.
    Sheean G
    Drug Saf; 2006; 29(1):31-48. PubMed ID: 16454533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of botulinum toxin to clinical therapy: advances and cautions.
    Levy NS; Lowenthal DT
    Am J Ther; 2012 Jul; 19(4):281-6. PubMed ID: 22481607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unlabeled uses of botulinum toxins: a review, part 2.
    Cheng CM; Chen JS; Patel RP
    Am J Health Syst Pharm; 2006 Feb; 63(3):225-32. PubMed ID: 16434781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between patient-reported chronic low back pain severity and medication resources.
    Taylor-Stokes G; Lobosco S; Pike J; Sadosky AB; Ross E
    Clin Ther; 2011 Nov; 33(11):1739-48. PubMed ID: 22001357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Use of Analgesic and Other Pain-Relief Drugs to Manage Chronic Low Back Pain: Results from a National Survey.
    Gouveia N; Rodrigues A; Ramiro S; Eusébio M; Machado PM; Canhão H; Branco JC
    Pain Pract; 2017 Mar; 17(3):353-365. PubMed ID: 27206719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum neurotoxins in the treatment of refractory pain.
    Jabbari B
    Nat Clin Pract Neurol; 2008 Dec; 4(12):676-85. PubMed ID: 19043424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum Toxin: Pharmacology and Therapeutic Roles in Pain States.
    Patil S; Willett O; Thompkins T; Hermann R; Ramanathan S; Cornett EM; Fox CJ; Kaye AD
    Curr Pain Headache Rep; 2016 Mar; 20(3):15. PubMed ID: 26879873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decision making in surgical treatment of chronic low back pain: the performance of prognostic tests to select patients for lumbar spinal fusion.
    Willems P
    Acta Orthop Suppl; 2013 Feb; 84(349):1-35. PubMed ID: 23427903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analgesic Effects of Botulinum Toxin in Children with CP.
    Sandahl Michelsen J; Normann G; Wong C
    Toxins (Basel); 2018 Apr; 10(4):. PubMed ID: 29671771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin type B: a new injectable treatment for cervical dystonia.
    Brashear A
    Expert Opin Investig Drugs; 2001 Dec; 10(12):2191-9. PubMed ID: 11772315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cervical dystonia treatment with botulin toxin].
    Tomczykiewicz K
    Pol Merkur Lekarski; 2016 Aug; 41(242):107-10. PubMed ID: 27591450
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.